Fuji Pharma Dividend
Dividend criteria checks 4/6
Fuji Pharma is a dividend paying company with a current yield of 2.72% that is well covered by earnings. Next payment date is on 23rd December, 2024 with an ex-dividend date of 27th September, 2024.
Key information
2.7%
Dividend yield
8%
Payout ratio
Industry average yield | 2.4% |
Next dividend pay date | 23 Dec 24 |
Ex dividend date | 27 Sep 24 |
Dividend per share | n/a |
Earnings per share | JP¥243.50 |
Dividend yield forecast in 3Y | 3.3% |
Recent dividend updates
Fuji Pharma (TSE:4554) Has Announced That It Will Be Increasing Its Dividend To ¥22.50
Jun 19Fuji Pharma (TSE:4554) Will Pay A Larger Dividend Than Last Year At ¥22.50
May 13Fuji Pharma's (TSE:4554) Dividend Will Be ¥20.00
Feb 28Recent updates
Fuji Pharma (TSE:4554) Has Announced That It Will Be Increasing Its Dividend To ¥22.50
Jun 19Impressive Earnings May Not Tell The Whole Story For Fuji Pharma (TSE:4554)
May 21Fuji Pharma (TSE:4554) Will Pay A Larger Dividend Than Last Year At ¥22.50
May 13Fuji Pharma's (TSE:4554) Dividend Will Be ¥20.00
Feb 28Upcoming Dividend Payment
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 4554's dividends per share have been stable in the past 10 years.
Growing Dividend: 4554's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
Fuji Pharma Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (4554) | 2.7% |
Market Bottom 25% (JP) | 1.7% |
Market Top 25% (JP) | 3.4% |
Industry Average (Pharmaceuticals) | 2.4% |
Analyst forecast in 3 Years (4554) | 3.3% |
Notable Dividend: 4554's dividend (2.72%) is higher than the bottom 25% of dividend payers in the JP market (1.69%).
High Dividend: 4554's dividend (2.72%) is low compared to the top 25% of dividend payers in the JP market (3.4%).
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (8.2%), 4554's dividend payments are thoroughly covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: 4554 is paying a dividend but the company has no free cash flows.